Delivery Order SPE2DB20D2014-SPE2DB25FB88V

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,806.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Vraylar 3 mg capsules, a medication used to treat certain mental health conditions. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen...
This federal contract award, valued at $22,390.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Vraylar 1.5 mg capsules, a medication used to treat various mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,832.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has a firm fixed price and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $3,558.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a prescription medication, over a performance period ending on April 9, 2025. The contract is a firm-fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award, valued at $1,115.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4.5 mg Vraylar capsules, a prescription medication, with a performance period through April 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award, valued at $1,543.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Vraylar 3 mg capsule in quantities of 30. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $3,050.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The award is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $58,088.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,925,531 units of the prescription medication Vraylar 1.5 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $13,671.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. This is a Firm Fixed Price Delivery Order contract with a completion date of January 7, 2025. The contract is not designated as a set-aside award, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,220.74 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a neurological medication. The contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB88V
    Delivery Order

This federal contract award, valued at $9,138.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the provision of Vraylar 3 mg capsules, a medication used to treat certain mental health conditions.

The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle. This prime contract enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 8/6/25, 10:00 AM